Purchases and Sales Made in Q4 2022 in Arcus Biosciences, Inc. (RCUS)
This table provides information about the institutional ownership of Arcus Biosciences, Inc. (RCUS) during Q4 2022. The information is specifically focused on institutions that hold shares of Arcus Biosciences, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-2.8K- 47.36% |
$55.1K - $99.8K
|
3.11K
$28.5K
|
|
Feb 10, 2023
Q4 2022
|
Great West Life Assurance CO
Winnipeg, A2 |
SELL
|
- |
-3.8K- 6.69% |
$74.8K - $136K
|
53K
$485K
|
|
Feb 14, 2023
Q4 2022
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-4.96K- 2.37% |
$97.6K - $177K
|
204K
$1.87M
|
|
Feb 14, 2023
Q4 2022
|
Vident Investment Advisory, LLC
Alpharetta, GA |
SELL
|
- |
-5.29K- 18.14% |
$104K - $189K
|
23.9K
$219K
|
|
Feb 14, 2023
Q4 2022
|
E Fund Management Co., Ltd.
Guangzhou, F4 |
SELL
|
- |
-5.51K- 35.03% |
$108K - $197K
|
10.2K
$93.6K
|
|
Jan 26, 2023
Q4 2022
|
Strs Ohio
|
SELL
|
- |
-6.5K- 19.94% |
$128K - $232K
|
26.1K
$239K
|
|
Feb 14, 2023
Q4 2022
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-6.89K- 38.73% |
$136K - $246K
|
10.9K
$99.8K
|
|
Feb 14, 2023
Q4 2022
|
Putnam Investments LLC
Boston, MA |
SELL
|
- |
-7K- 5.05% |
$138K - $250K
|
132K
$1.21M
|
|
Feb 01, 2023
Q4 2022
|
Anfield Capital Management, LLC
Newport Beach, CA |
SELL
|
- |
-7.51K- 93.4% |
$148K - $268K
|
531
$4.86K
|
|
Feb 14, 2023
Q4 2022
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-7.97K- 23.55% |
$157K - $285K
|
25.9K
$237K
|
|
Jan 26, 2023
Q4 2022
|
Comerica Bank
|
SELL
|
- |
-8.68K- 21.87% |
$171K - $310K
|
31K
$284K
|
|
Jan 09, 2023
Q4 2022
|
Yousif Capital Management, LLC
|
SELL
|
- |
-8.77K- 19.86% |
$173K - $313K
|
35.4K
$324K
|
|
Feb 13, 2023
Q4 2022
|
Gyon Technologies Capital Management, LP
Denville, NJ |
SELL
|
- |
-9.57K- 36.04% |
$189K - $342K
|
17K
$156K
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-10.5K- 7.0% |
$206K - $374K
|
139K
$1.27M
|
|
Feb 14, 2023
Q4 2022
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-11.9K- 30.73% |
$234K - $425K
|
26.8K
$246K
|
|
Feb 09, 2023
Q4 2022
|
Principal Financial Group Inc
Des Moines, IA |
SELL
|
- |
-12.2K- 3.58% |
$240K - $436K
|
329K
$3.01M
|
|
Feb 14, 2023
Q4 2022
|
Bellevue Group Ag
Kuesnacht, V8 |
SELL
|
- |
-17.6K- 21.12% |
$347K - $630K
|
65.9K
$603K
|
|
Feb 14, 2023
Q4 2022
|
Pdt Partners, LLC
New York, NY |
SELL
|
- |
-19.9K- 34.0% |
$392K - $711K
|
38.6K
$354K
|
|
Feb 14, 2023
Q4 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-22K- 21.14% |
$433K - $785K
|
82K
$751K
|
|
Feb 13, 2023
Q4 2022
|
Algert Global LLC
San Francisco, CA |
SELL
|
- |
-22.9K- 63.13% |
$451K - $818K
|
13.4K
$123K
|
|
Feb 01, 2023
Q4 2022
|
Deka Bank Deutsche Girozentrale
|
SELL
|
- |
-23K- 53.49% |
$453K - $821K
|
20K
$183K
|
|
Feb 14, 2023
Q4 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-24.4K- 14.61% |
$480K - $870K
|
142K
$1.3M
|
|
Feb 13, 2023
Q4 2022
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-33.6K- 14.7% |
$662K - $1.2M
|
195K
$1.79M
|
|
Feb 14, 2023
Q4 2022
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-36.5K- 20.42% |
$719K - $1.3M
|
142K
$1.3M
|
|
Feb 13, 2023
Q4 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-42.7K- 25.29% |
$841K - $1.52M
|
126K
$1.15M
|
|
Feb 14, 2023
Q4 2022
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-45K- 10.07% |
$886K - $1.61M
|
402K
$3.68M
|
|
Feb 13, 2023
Q4 2022
|
Parkman Healthcare Partners LLC
Stamford, CT |
SELL
|
- |
-50.4K- 36.57% |
$994K - $1.8M
|
87.5K
$801K
|
|
Feb 14, 2023
Q4 2022
|
Tang Capital Management LLC
San Diego, CA |
SELL
|
- |
-52.1K- 26.04% |
$1.03M - $1.86M
|
148K
$1.35M
|
|
Feb 13, 2023
Q4 2022
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-66.5K- 17.45% |
$1.31M - $2.38M
|
315K
$2.88M
|
|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-84K- 1.88% |
$1.65M - $3M
|
4.37M
$40.1M
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-101K- 11.69% |
$1.99M - $3.61M
|
762K
$6.98M
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-101K- 11.69% |
$1.99M - $3.61M
|
762K
$6.98M
|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
SELL
|
- |
-108K- 46.02% |
$2.13M - $3.86M
|
127K
$1.16M
|
|
Feb 13, 2023
Q4 2022
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-149K- 73.91% |
$2.94M - $5.34M
|
52.8K
$483K
|
|
Feb 14, 2023
Q4 2022
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-151K- 14.61% |
$2.98M - $5.41M
|
885K
$8.11M
|
|
Feb 14, 2023
Q4 2022
|
Octagon Capital Advisors LP
New York, NY |
SELL
|
- |
-187K- 7.01% |
$3.69M - $6.69M
|
2.48M
$22.7M
|
|
Feb 13, 2023
Q4 2022
|
Pictet Asset Management Sa
Geneva 73, V8 |
SELL
|
- |
-225K- 15.14% |
$4.44M - $8.05M
|
1.26M
$11.6M
|
|
Feb 14, 2023
Q4 2022
|
Bvf Inc
San Francisco, CA |
SELL
|
- |
-414K- 15.22% |
$8.15M - $14.8M
|
2.3M
$21.1M
|
|
Feb 14, 2023
Q4 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-598K- 14.43% |
$11.8M - $21.3M
|
3.54M
$32.5M
|
|
Feb 14, 2023
Q4 2022
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-680K- 20.1% |
$13.4M - $24.3M
|
2.7M
$24.8M
|